Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

interchemie werken de adelaar eesti as - calcium gluconate monohydrate; magnesium chloride hexahydrate; boric acid - innrennslislyf, lausn - 380mg/60mg/50 mg/ml

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - stækkun Æxli, gelding-Þola - Æxlishemjandi lyf - treatment of adult patients with prostate cancer.

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 5 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - ibandronate sodium monohydrate - filmuhúðuð tafla - 50 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - ibandronate sodium monohydrate - filmuhúðuð tafla - 150 mg

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.